Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ana Filipa Alexandre"'
Autor:
Ana Filipa Alexandre, Antonia Morga, Caitlin Thomas, Nicolas Krucien, Tommi Tervonen, Alina Jiletcovici, Kevin Marsh
Publikováno v:
Advances in Therapy. 40:641-657
Information about patient preferences for the treatment of anaemia associated with chronic kidney disease (CKD) is scarce. Hence, our aim was to examine how patients with non-dialysis-dependent CKD valued attributes of alternative hypothetical anaemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f96b4c0d0207c4d182bcfcf96c147e0
https://doi.org/10.1007/s12325-022-02367-z
https://doi.org/10.1007/s12325-022-02367-z
Autor:
Steven McCarus, Ana Filipa Alexandre, Tomomi Kimura, Qi Feng, Wei Han, Emily F. Shortridge, Robson Barbosa Lima, Jason Schwartz, Steven D. Wexner
Publikováno v:
Advances in Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b60826703fbe9401dae5401c9592caa
https://doi.org/10.1007/s12325-023-02515-z
https://doi.org/10.1007/s12325-023-02515-z
Autor:
Alexandros Georgiadis, Celine Desvignes-Gleizes, Antonia Morga, Ana Filipa Alexandre, Patricia Koochaki
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Anaemia is a common complication of CKD in children that is associated with adverse clinical outcomes, including poor physical functioning for patients and lower HRQoL for patients and caregivers.1 Given the subjective nature of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6aa4190b51d68f02a5402518c321da6a
https://doi.org/10.1093/ndt/gfab085.0018
https://doi.org/10.1093/ndt/gfab085.0018
Autor:
Bengt Fellström, Ana Filipa Alexandre, James Young, Alina Jiletcovici, Knut Smerud, Niclas Eriksson, Antonia Morga, Elinor Cockburn, Wim Wilpshaar
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Patients with chronic kidney disease (CKD) are at higher risk of cardiovascular disease (CVD), which can also lead to end-stage renal disease (ESRD).1 As anaemia is an independent risk factor for CVD,2 treating anaemia might reduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5ee9f54dacd4ca8e7221540b7c6d347
https://doi.org/10.1093/ndt/gfab085.006
https://doi.org/10.1093/ndt/gfab085.006
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Anaemia is a common complication of chronic kidney disease (CKD) that is associated with fatigue, shortness of breath, and lethargy. CKD anaemia is commonly treated with oral or intravenous (IV) iron and IV or subcutaneous (SC) er
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7e00509e05471644ddfad19c7e3bf63
https://doi.org/10.1093/ndt/gfaa142.p0865
https://doi.org/10.1093/ndt/gfaa142.p0865
Autor:
Grace Kiyabu, Tadao Akizawa, Ayako Fukushima, Julie Dorey, Ana Filipa Alexandre, Hiroyuki Okumura
Publikováno v:
Therapeutic Apheresis and Dialysis. 22:444-456
Anemia is a common complication for patients with chronic kidney disease (CKD) and is associated with cardiovascular comorbidities and reduced quality of life. The incidence of anemia increases as kidney function declines and affects approximately 32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8d23304fa5aa7eba8b43b8b9e7fd3fc
https://doi.org/10.1111/1744-9987.12712
https://doi.org/10.1111/1744-9987.12712
Autor:
Antonia Morga, Chris Atzinger, Mick Arber, Sarah King, Angaja Phalguni, Alice Sanderson, Ana Filipa Alexandre
Publikováno v:
Blood. 138:4152-4152
OBJECTIVES: While chemotherapy is fundamental to the treatment of many cancers, it is associated with adverse events (AEs), including anemia. CIA is linked to many symptoms, including fatigue and cognitive impairment. Most cancer patients receiving c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecf2a596c0cfb979da0079272ebe156d
https://doi.org/10.1182/blood-2021-144957
https://doi.org/10.1182/blood-2021-144957
Publikováno v:
Blood. 138:5025-5025
OBJECTIVES: Chemotherapy-induced anemia (CIA) is a common adverse event of cancer treatment and is associated with several symptoms that negatively impact health-related quality of life (HRQoL). Due to the nature of CIA signs and symptoms, the use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5475db2f026cd2880618c97e8d998ae
https://doi.org/10.1182/blood-2021-144747
https://doi.org/10.1182/blood-2021-144747
Publikováno v:
Journal of the American College of Surgeons. 233:e25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41aaf7e9fba9e0366d641a149122de73
https://doi.org/10.1016/j.jamcollsurg.2021.08.069
https://doi.org/10.1016/j.jamcollsurg.2021.08.069
Publikováno v:
Journal of the American College of Surgeons. 233:e129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fde99efd761dcb2f35a4aee1c6f80620
https://doi.org/10.1016/j.jamcollsurg.2021.08.349
https://doi.org/10.1016/j.jamcollsurg.2021.08.349